Managing high blood pressure is a constant challenge for many adults. While many people start with two medications, some find it difficult to reach their target numbers. New data suggests that moving from a dual therapy to a triple therapy—using three different medications at once—can make a meaningful difference in reaching those goals.
A large review of clinical trials involving over 13,000 adults found that triple therapy led to greater reductions in systolic blood pressure compared to dual therapy. Specifically, patients on three drugs saw an average drop of 26.9 mmHg, while those on two drugs saw a drop of 21.7 mmHg. Beyond just the numbers, more people achieved overall blood pressure control on the triple regimen, with success rates reaching 60% compared to 47% for dual therapy.
Safety is always a concern when adding more medication. The study found that triple therapy was well-tolerated by patients. While there was a slightly higher rate of people stopping treatment due to side effects in the triple group (4%) compared to the dual group (3%), the difference was small. These results suggest that for those struggling to manage their blood pressure, adding a third medication can be an effective and manageable step.
